HomeDVAX • NASDAQ
add
Dynavax Technologies Corp
Previous close
$9.82
Day range
$9.61 - $9.84
Year range
$9.22 - $14.63
Market cap
1.18B USD
Avg Volume
2.52M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 68.16M | 34.21% |
Operating expense | 57.02M | 22.99% |
Net income | -96.10M | -1,001.93% |
Net profit margin | -140.98 | -721.08% |
Earnings per share | -0.01 | 87.00% |
EBITDA | -20.23M | -10.87% |
Effective tax rate | 1.81% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 661.34M | -8.60% |
Total assets | 945.93M | -4.12% |
Total liabilities | 414.99M | 12.74% |
Total equity | 530.94M | — |
Shares outstanding | 120.08M | — |
Price to book | 2.29 | — |
Return on assets | -5.54% | — |
Return on capital | -6.40% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -96.10M | -1,001.93% |
Cash from operations | -19.64M | -17.75% |
Cash from investing | 6.91M | 144.08% |
Cash from financing | -31.88M | -658.55% |
Net change in cash | -44.15M | -141.91% |
Free cash flow | -32.56M | -91.48% |
About
CEO
Founded
1996
Headquarters
Website
Employees
405